These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8735736

  • 1. Epithelial ovarian carcinoma of low malignant potential.
    Darai E, Teboul J, Walker F, Benifla JL, Meneux E, Guglielmina JN, Pennehouat G, Renolleau C, Sebban E, Madelenat P.
    Eur J Obstet Gynecol Reprod Biol; 1996 Jun; 66(2):141-5. PubMed ID: 8735736
    [Abstract] [Full Text] [Related]

  • 2. [Borderline ovarian tumors: a series of 43 patients].
    Darai E, Teboul J, Walker-Combrouze F, Fauconnier A, Bénifla JL, Meneux E, Panel P, Benzakine Y, Tardif D, Madelenat P.
    Contracept Fertil Sex; 1997 Dec; 25(12):933-8. PubMed ID: 9497606
    [Abstract] [Full Text] [Related]

  • 3. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy.
    Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P.
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):451-7. PubMed ID: 9598957
    [Abstract] [Full Text] [Related]

  • 4. Laparoscopic restaging of borderline ovarian tumors.
    Daraï E, Tulpin L, Prugnolle H, Cortez A, Dubernard G.
    Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY, Shen K, Tao T, Yang JX, Xiang Y, Huang HF, Wu M, Pan LY, Lang JH.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [Abstract] [Full Text] [Related]

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 7. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D'argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E.
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [Abstract] [Full Text] [Related]

  • 8. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study.
    Fauvet R, Boccara J, Dufournet C, Poncelet C, Daraï E.
    Ann Oncol; 2005 Mar; 16(3):403-10. PubMed ID: 15653700
    [Abstract] [Full Text] [Related]

  • 9. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG, Deavers MT, Veras E, Silva EG, Gershenson D, Malpica A.
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [Abstract] [Full Text] [Related]

  • 10. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M, Pan LY, Huang HF, Lang JH.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [Abstract] [Full Text] [Related]

  • 11. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P.
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E.
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [Abstract] [Full Text] [Related]

  • 13. Are borderline tumors of the ovary safely treated by laparoscopy?
    Maneo A, Vignali M, Chiari S, Colombo A, Mangioni C, Landoni F.
    Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
    De Iaco P, Ferrero A, Rosati F, Melpignano M, Biglia N, Rolla M, De Aloysio D, Sismondi P.
    Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
    [Abstract] [Full Text] [Related]

  • 16. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I, de Sousa Mendes M.
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [Abstract] [Full Text] [Related]

  • 17. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 18. Epithelial ovarian tumors of borderline malignancy.
    Chao TM, Yen MS, Chao KC, Ng HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [Abstract] [Full Text] [Related]

  • 19. Preoperative serum CA-125 levels in borderline tumors of the ovary.
    Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA.
    Gynecol Oncol; 1992 Aug; 46(2):226-9. PubMed ID: 1500026
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.